ArticleArthritis & rheumatology (Hoboken, N.J.)2017

Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid Arthritis.

Jing Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.